{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:05:10Z","timestamp":1784005510507,"version":"3.55.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019643","name":"State Key Laboratory of Radiation Medicine and Protection","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013323","name":"Yancheng Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of postoperative radiotherapy (PORT) in patients with radically resected esophageal squamous cell carcinoma (ESCC) remains controversial. This meta-analysis aimed to evaluate the efficacy of PORT compared with surgery alone in terms of survival outcomes and toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was performed in PubMed, EMBASE, and the Cochrane Library from January 1990 to June 2025 for randomized controlled trials (RCTs) and retrospective studies (RSs) comparing PORT versus surgery alone in ESCC patients who underwent curative resection. Primary outcomes were overall survival (OS) and disease-free survival (DFS), reported as hazard ratios (HRs) with 95% confidence intervals (CIs). Secondary outcomes included locoregional recurrence (LRR), distant metastasis (DM), and treatment toxicity. Quality was assessed using the revised Cochrane risk-of-bias tool (ROB2) for RCTs and the Newcastle-Ottawa Scale (NOS) for retrospective studies. The Jadad scale was also applied for consistency with previous meta-analyses. Meta-regression and subgroup analyses were performed to explore heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-five studies (8 RCTs, 27 RSs) comprising 11,385 patients (4,968 in the PORT group, 6,417 in the surgery alone group) were included. PORT significantly improved OS (HR = 0.74, 95% CI: 0.69\u20130.80,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001,\n                      <jats:italic>I<\/jats:italic>\n                      \u00b2 = 67%) and DFS (HR = 0.62, 95% CI: 0.58\u20130.67,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001,\n                      <jats:italic>I<\/jats:italic>\n                      \u00b2 = 47%) compared with surgery alone. PORT significantly reduced LRR (OR = 0.30, 95% CI: 0.27\u20130.34,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001,\n                      <jats:italic>I<\/jats:italic>\n                      \u00b2 = 0%) but had no effect on DM (OR = 1.01, 95% CI: 0.92\u20131.11,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.85,\n                      <jats:italic>I<\/jats:italic>\n                      \u00b2 = 0%). Subgroup analyses showed that PORT improved OS in patients with positive lymph nodes (HR = 0.65), T3-4 stage (HR = 0.72), R0 resection (HR = 0.72), and those receiving modern radiotherapy (3D-CRT\/IMRT, HR = 0.67). The addition of chemotherapy yielded the greatest OS benefit (HR = 0.55). PORT was associated with a significantly higher incidence of grade \u22653 acute toxicity (OR = 2.45, 95% CI: 1.89\u20133.18,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001), mainly radiation esophagitis (12.5%) and leukopenia (15.2%), but grade \u22654 toxicity was rare (&amp;lt;5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For patients with radically resected ESCC, PORT significantly improves OS and DFS and reduces LRR, especially in those with high-risk features. A radiation dose of 50 Gy is recommended to achieve optimal benefit. Although PORT increases acute toxicity, it is generally manageable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/search<\/jats:ext-link>\n                      , Identifier CRD420261400043.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1878657","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:21:48Z","timestamp":1784002908000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative radiotherapy for resected esophageal squamous cell carcinoma: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Ning","family":"Zhou","sequence":"first","affiliation":[{"name":"The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Affiliated Hospital of Jiangsu University","place":["Zhenjiang, China"]},{"name":"Yancheng First People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Yanchengsh Second People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Affiliated Hospital of Jiangsu University","place":["Zhenjiang, China"]},{"name":"Yancheng First People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wen","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Affiliated Hospital of Jiangsu University","place":["Zhenjiang, China"]},{"name":"Yancheng First People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Geng","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Affiliated Hospital of Jiangsu University","place":["Zhenjiang, China"]},{"name":"Yancheng First People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Affiliated Hospital of Jiangsu University","place":["Zhenjiang, China"]},{"name":"Yancheng First People\u2019s Hospital","place":["Yancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.06.046","article-title":"A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma","volume":"80","author":"Lin","year":"2020","journal-title":"Int J Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1308\/003588409X432428","article-title":"The management of a patient with an operable carcinoma of the oesophagus","volume":"91","author":"Crosby","year":"2009","journal-title":"Ann R Coll Surg Engl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(02)04401-6","article-title":"Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients","volume":"75","author":"Xiao","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B6","article-title":"Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study","volume":"113","author":"Fok","year":"1993","journal-title":"Surgery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/BF00299187","article-title":"Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study","volume":"19","author":"Zieren","year":"1995","journal-title":"World J Surg"},{"key":"B8","article-title":"Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research","volume":"173","author":"T\u00e9ni\u00e8re","year":"1991","journal-title":"Surg Gynecol Obstet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.06.65","article-title":"The role of postoperative radiotherapy for radically resected esophageal squamous cell carcinoma: a systemic review and meta-analysis","volume":"10","author":"Liu","year":"2018","journal-title":"J Thorac Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.03.024","article-title":"The impact of postoperative conformal radiotherapy after radical surgery on survival and recurrence in pathologic T3N0M0 esophageal carcinoma: a propensity score-matched analysis","volume":"12","author":"Yang","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000375391","article-title":"Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma","volume":"38","author":"Zhang","year":"2015","journal-title":"Oncol Res Treat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235879","article-title":"Effect of adjuvant radiation dose on survival in patients with esophageal squamous cell carcinoma","volume":"14","author":"Han","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13914","article-title":"Postoperative adjuvant therapy versus surgery alone for stage IIB-III esophageal squamous cell carcinoma: a phase III randomized controlled trial","volume":"26","author":"Ni","year":"2021","journal-title":"Oncologist"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02528-0","article-title":"Propensity-matched study on locally advanced esophageal cancer: surgery versus post-operative radiotherapy","volume":"19","author":"Zeng","year":"2024","journal-title":"Radiat Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0276","article-title":"Postoperative radiotherapy in pathological T2-3N0M0 thoracic esophageal squamous cell carcinoma: interim report of a prospective, phase III, randomized controlled study","volume":"25","author":"Deng","year":"2020","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.06.020","article-title":"A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy","volume":"140","author":"Yu","year":"2019","journal-title":"Radiother Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8571438","article-title":"Postoperative adjuvant therapy for patients with pN+ esophageal squamous cell carcinoma","volume":"2021","author":"Li","year":"2021","journal-title":"BioMed Res Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i13.1649","article-title":"Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma","volume":"16","author":"Lv","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijrobp.2004.08.046","article-title":"Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases","volume":"62","author":"Xiao","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2041-z","article-title":"The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma","volume":"142","author":"Chen","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13088","article-title":"Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: results from a Chinese two-center study","volume":"10","author":"Ni","year":"2019","journal-title":"Thorac Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/jca.16409","article-title":"Adjuvant therapy for a microscopically incomplete resection margin after an esophagectomy for esophageal squamous cell carcinoma","volume":"8","author":"Qiu","year":"2017","journal-title":"J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2016.142","article-title":"Optimal adjuvant treatment for curatively resected thoracic esophageal squamous cell carcinoma: a radiotherapy perspective","volume":"49","author":"Kim","year":"2017","journal-title":"Cancer Res Treat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.08.037","article-title":"Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma","volume":"82","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejcts.2008.09.002","article-title":"Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus","volume":"35","author":"Chen","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"B26","first-page":"67","article-title":"Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus","volume":"54","author":"Shimizu","year":"2005","journal-title":"Hiroshima J Med Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-020-00790-1","article-title":"Efficacy of postoperative radiotherapy in esophageal squamous cell carcinoma patients with positive circumferential resection margin","volume":"18","author":"Otake","year":"2021","journal-title":"Esophagus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.03.015","article-title":"Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma","volume":"98","author":"Zhang","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.959568","article-title":"Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer","volume":"9","author":"Song","year":"2022","journal-title":"Front Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08667-4","article-title":"Perineural invasion is a better prognostic indicator than lymphovascular invasion and a potential adjuvant therapy indicator for pN0M0 esophageal squamous cell carcinoma","volume":"27","author":"Guo","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4622-0","article-title":"Postoperative radiotherapy improves survival in stage pT2N0M0 esophageal squamous cell carcinoma with high risk of poor prognosis","volume":"23","author":"Wang","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241285142","article-title":"Postoperative radiotherapy in curatively resected esophageal squamous cell carcinoma with occult recurrent laryngeal nerve lymph node metastasis","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Ctrl"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2010.04.002","article-title":"Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus","volume":"90","author":"Chen","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12355","article-title":"Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: an analysis of clinical outcomes","volume":"7","author":"Zou","year":"2016","journal-title":"Thorac Cancer"},{"key":"B35","first-page":"282","article-title":"Prognostic factors in patients with thoracic esophageal carcinoma staged pT1-4aN0M0 undergone esophagectomy with three-field lymphadenectomy","volume":"3","author":"Chen","year":"2015","journal-title":"Ann Transl Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-116","article-title":"Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer","volume":"8","author":"Xu","year":"2013","journal-title":"Radiat Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.12.041","article-title":"Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma","volume":"97","author":"Hsu","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23313","article-title":"The influence of circumferential resection margin status on loco-regional recurrence in esophageal squamous cell carcinoma","volume":"107","author":"Park","year":"2013","journal-title":"J Surg Oncol"},{"key":"B39","article-title":"The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma","volume":"8","author":"Ning","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S232930","article-title":"The role of adjuvant chemoradiotherapy over radiotherapy after R0 resection for stage II-III esophageal squamous cell carcinoma","volume":"12","author":"Song","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J Clin Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.02.015","article-title":"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer","volume":"84","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4730","article-title":"Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70098-6","article-title":"Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies","volume":"9","author":"Veldeman","year":"2008","journal-title":"Lancet Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2003.10.005","article-title":"Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy","volume":"198","author":"Nakagawa","year":"2004","journal-title":"J Am Coll Surg"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-7596-4","article-title":"Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma","volume":"29","author":"Doki","year":"2005","journal-title":"World J Surg"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11228","article-title":"Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease","volume":"97","author":"Mariette","year":"2003","journal-title":"Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.652365","article-title":"Pattern of recurrence in 428 patients with thoracic esophageal squamous cell carcinoma after radical surgery and its implication in postoperative radiotherapeutic clinical target volume","volume":"11","author":"Cui","year":"2021","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2022.09.001","article-title":"Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence","volume":"27","author":"Xu","year":"2023","journal-title":"Cancer Radiother"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.04.029","article-title":"Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy","volume":"96","author":"Cai","year":"2010","journal-title":"Radiother Oncol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100956","article-title":"Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma","volume":"14","author":"Lin","year":"2021","journal-title":"Transl Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8548694","article-title":"Comparison and prognostic analysis of adjuvant radiotherapy versus salvage radiotherapy for treatment of radically resected locally advanced esophageal squamous cell carcinoma","volume":"2016","author":"Xu","year":"2016","journal-title":"BioMed Res Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijrobp.2007.06.031","article-title":"Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma","volume":"70","author":"Qiao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doz013","article-title":"Randomized phase II trial comparing tumor bed alone with tumor bed and elective nodal postoperative radiotherapy in patients with locoregionally advanced thoracic esophageal squamous cell carcinoma","volume":"32","author":"Cai","year":"2019","journal-title":"Dis Esophagus"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.669575","article-title":"The prognosis and feasibility of extensive clinical target volume in postoperative radiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.03.026","article-title":"Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma","volume":"86","author":"Chen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1878657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:21:50Z","timestamp":1784002910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1878657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":63,"alternative-id":["10.3389\/fonc.2026.1878657"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1878657","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"1878657"}}